381 related articles for article (PubMed ID: 20476787)
1. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.
Matsubara T; Sumi M; Kubota H; Taki T; Okahata Y; Sato T
J Med Chem; 2009 Jul; 52(14):4247-56. PubMed ID: 19558186
[TBL] [Abstract][Full Text] [Related]
3. Heptapeptide ligands against receptor-binding sites of influenza hemagglutinin toward anti-influenza therapy.
Matsubara T; Onishi A; Yamaguchi D; Sato T
Bioorg Med Chem; 2016 Mar; 24(5):1106-14. PubMed ID: 26833245
[TBL] [Abstract][Full Text] [Related]
4. Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid.
Takahashi T; Hashimoto A; Maruyama M; Ishida H; Kiso M; Kawaoka Y; Suzuki Y; Suzuki T
FEBS Lett; 2009 Oct; 583(19):3171-4. PubMed ID: 19720062
[TBL] [Abstract][Full Text] [Related]
5. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007.
Zaraket H; Saito R; Sato I; Suzuki Y; Li D; Dapat C; Caperig-Dapat I; Oguma T; Sasaki A; Suzuki H
Arch Virol; 2009; 154(2):285-95. PubMed ID: 19153639
[TBL] [Abstract][Full Text] [Related]
6. Hemagglutinin protein of Asian strains of human influenza virus A H1N1 binds to sialic acid--a major component of human airway receptors.
Chua KH; Chai HC
Genet Mol Res; 2012 Mar; 11(1):636-43. PubMed ID: 22535399
[TBL] [Abstract][Full Text] [Related]
7. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.
Matrosovich MN; Gambaryan AS; Teneberg S; Piskarev VE; Yamnikova SS; Lvov DK; Robertson JS; Karlsson KA
Virology; 1997 Jun; 233(1):224-34. PubMed ID: 9201232
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of sialic acid derivatives containing a long hydrophobic chain at the anomeric position and their C-5 linked polymers as potent influenza virus inhibitors.
Suzuki K; Koyama T; Yingsakmongkon S; Suzuki Y; Hatano K; Matsuoka K
Bioorg Med Chem; 2012 Jan; 20(1):446-54. PubMed ID: 22100261
[TBL] [Abstract][Full Text] [Related]
9. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.
Hidari KI; Murata T; Yoshida K; Takahashi Y; Minamijima YH; Miwa Y; Adachi S; Ogata M; Usui T; Suzuki Y; Suzuki T
Glycobiology; 2008 Oct; 18(10):779-88. PubMed ID: 18621993
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance.
Mandenius CF; Wang R; Aldén A; Bergström G; Thébault S; Lutsch C; Ohlson S
Anal Chim Acta; 2008 Aug; 623(1):66-75. PubMed ID: 18611459
[TBL] [Abstract][Full Text] [Related]
11. HA-pseudotyped retroviral vectors for influenza antagonist screening.
Wang SY; Su CY; Lin M; Huang SY; Huang WI; Wang CC; Wu YT; Cheng TJ; Yu HM; Ren CT; Wu CY; Wong CH; Cheng YS
J Biomol Screen; 2009 Mar; 14(3):294-302. PubMed ID: 19211776
[TBL] [Abstract][Full Text] [Related]
12. Highly conserved sequences for human neutralization epitope on hemagglutinin of influenza A viruses H3N2, H1N1 and H5N1: Implication for human monoclonal antibody recognition.
Yamashita A; Kawashita N; Kubota-Koketsu R; Inoue Y; Watanabe Y; Ibrahim MS; Ideno S; Yunoki M; Okuno Y; Takagi T; Yasunaga T; Ikuta K
Biochem Biophys Res Commun; 2010 Mar; 393(4):614-8. PubMed ID: 20152806
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
[TBL] [Abstract][Full Text] [Related]
14. In silico characterization of the functional and structural modules of the hemagglutinin protein from the swine-origin influenza virus A (H1N1)-2009.
Sun Y; Shi Y; Zhang W; Li Q; Liu D; Vavricka C; Yan J; Gao GF
Sci China Life Sci; 2010 Jun; 53(6):633-42. PubMed ID: 20602265
[TBL] [Abstract][Full Text] [Related]
15. Screening from the world's largest TCM database against H1N1 virus.
Chang TT; Sun MF; Chen HY; Tsai FJ; Fisher M; Lin JG; Chen CY
J Biomol Struct Dyn; 2011 Apr; 28(5):773-86. PubMed ID: 21294588
[TBL] [Abstract][Full Text] [Related]
16. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
17. Receptor specificity of the influenza virus hemagglutinin modulates sensitivity to soluble collectins of the innate immune system and virulence in mice.
Tate MD; Brooks AG; Reading PC
Virology; 2011 Apr; 413(1):128-38. PubMed ID: 21419468
[TBL] [Abstract][Full Text] [Related]
18. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
An J; Lee DC; Law AH; Yang CL; Poon LL; Lau AS; Jones SJ
J Med Chem; 2009 May; 52(9):2667-72. PubMed ID: 19419201
[TBL] [Abstract][Full Text] [Related]
19. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides.
Nobusawa E; Ishihara H; Morishita T; Sato K; Nakajima K
Virology; 2000 Dec; 278(2):587-96. PubMed ID: 11118381
[TBL] [Abstract][Full Text] [Related]
20. Identifying discriminative amino acids within the hemagglutinin of human influenza A H5N1 virus using a decision tree.
Wu LC; Horng JT; Huang HD; Chen WL
IEEE Trans Inf Technol Biomed; 2008 Nov; 12(6):689-95. PubMed ID: 19000947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
